Brown Fat Activity and White Fat Accumulation
NCT01517581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2012-01-25
Summary
White and brown adipocytes differ in their expression of hormones, cytokines, and inflammatory factors, and they modulate different biological functions. While white adipose tissue (WAT) serves as the primary site of energy storage, brown adipose tissue (BAT) instead metabolizes fat to produce heat and regulate body temperature. BAT is likely present in all humans, but the low prevalence of BAT depiction in adults and elderly subjects has hindered longitudinal assessments of the relation between BAT activity and WAT. Under typical imaging conditions, BAT is detected more frequently in children and teenagers than in adults with malignancy. Since most children with cancer have significantly shorter treatment courses and greater survival rates compared to adult patients, the investigators have the ability to examine the relation of repeated measures of body composition and BAT by selecting pediatric patients. In this study, the investigators will longitudinally examine whether BAT activity is related to changes in weight and the amounts of SAT, VAT, and abdominal muscle in children successfully treated for pediatric cancer.
Conditions
- Hodgkins Lymphoma
- Non-hodgkins Lymphoma
Sponsors & Collaborators
-
Children's Hospital Los Angeles
lead OTHER
Principal Investigators
-
Vicente Gilsanz, MD, PhD · Children's Hospital Los Angeles
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
NCT05453396 ·Status: RECRUITING ·Phase: PHASE2
-
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia
NCT00324779 ·Status: COMPLETED ·Phase: PHASE2
-
Lean Body Mass and Side Effects in Patients With Lymphoma
NCT04698616 ·Status: UNKNOWN
-
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
NCT00900250 ·Status: COMPLETED
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
NCT05590221 ·Status: RECRUITING ·Phase: PHASE2
-
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
NCT01228461 ·Status: COMPLETED
-
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT00058461 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
NCT02929615 ·Status: UNKNOWN ·Phase: PHASE4
-
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
NCT00161187 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001237 ·Status: COMPLETED ·Phase: PHASE2
-
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
NCT05618925 ·Status: RECRUITING ·Phase: PHASE1
-
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
NCT07346157 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Complex Intervention for Chronically Fatigued Lymphoma Survivors
NCT05130099 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
NCT00551798 ·Status: COMPLETED ·Phase: NA
-
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
NCT05459571 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
NCT00169169 ·Status: TERMINATED ·Phase: PHASE3
-
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
NCT00176475 ·Status: TERMINATED ·Phase: PHASE1
-
Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant
NCT02109809 ·Status: TERMINATED ·Phase: NA
-
Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel
NCT05199961 ·Status: TERMINATED ·Phase: NA
-
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
NCT02896829 ·Status: COMPLETED
-
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
NCT05138458 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma
NCT06912529 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma
NCT03704298 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
NCT02315118 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2